BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22566862)

  • 1. Immunization with dendritic cells pulsed ex vivo with recombinant chlamydial protease-like activity factor induces protective immunity against genital chlamydiamuridarum challenge.
    Li W; Murthy AK; Chaganty BK; Guentzel MN; Seshu J; Chambers JP; Zhong G; Arulanandam BP
    Front Immunol; 2011; 2():73. PubMed ID: 22566862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.
    Li W; Murthy AK; Guentzel MN; Chambers JP; Forsthuber TG; Seshu J; Zhong G; Arulanandam BP
    Infect Immun; 2010 Sep; 78(9):3942-9. PubMed ID: 20605976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization with recombinant chlamydial protease-like activity factor attenuates atherosclerotic pathology following Chlamydia pneumoniae infection in mice.
    Li W; Gudipaty P; Li C; Henderson KK; Ramsey KH; Murthy AK
    Immunol Cell Biol; 2019 Jan; 97(1):85-91. PubMed ID: 30051926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs.
    Wali S; Gupta R; Yu JJ; Lanka GKK; Chambers JP; Guentzel MN; Zhong G; Murthy AK; Arulanandam BP
    Immunol Cell Biol; 2017 May; 95(5):454-460. PubMed ID: 27990018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.
    Li W; Guentzel MN; Seshu J; Zhong G; Murthy AK; Arulanandam BP
    Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge.
    Chaganty BK; Murthy AK; Evani SJ; Li W; Guentzel MN; Chambers JP; Zhong G; Arulanandam BP
    Vaccine; 2010 Mar; 28(11):2323-9. PubMed ID: 20056182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
    Murthy AK; Cong Y; Murphey C; Guentzel MN; Forsthuber TG; Zhong G; Arulanandam BP
    Infect Immun; 2006 Dec; 74(12):6722-9. PubMed ID: 17015458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
    Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
    J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.
    Cong Y; Jupelli M; Guentzel MN; Zhong G; Murthy AK; Arulanandam BP
    Vaccine; 2007 May; 25(19):3773-80. PubMed ID: 17349723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge.
    Murthy AK; Chaganty BK; Li W; Guentzel MN; Chambers JP; Seshu J; Zhong G; Arulanandam BP
    FEMS Immunol Med Microbiol; 2009 Mar; 55(2):271-9. PubMed ID: 19281569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity.
    Jiang X; Shen C; Rey-Ladino J; Yu H; Brunham RC
    Infect Immun; 2008 Jun; 76(6):2392-401. PubMed ID: 18362126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective.
    Shaw J; Grund V; Durling L; Crane D; Caldwell HD
    Infect Immun; 2002 Mar; 70(3):1097-105. PubMed ID: 11854188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of an enzymatically inactive CPAF mutant vaccination in Chlamydia muridarum genital tract infection.
    Chen H; Peng B; Yang C; Xie L; Zhong S; Sun Z; Li Z; Wang C; Liu X; Tang X; Zhong G; Lu C
    Microb Pathog; 2021 Nov; 160():105137. PubMed ID: 34390765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
    Su H; Messer R; Whitmire W; Fischer E; Portis JC; Caldwell HD
    J Exp Med; 1998 Sep; 188(5):809-18. PubMed ID: 9730883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
    Li Z; Wang S; Wu Y; Zhong G; Chen D
    Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with the defined chlamydial secreted protein CPAF induces robust protection against female infertility following repeated genital chlamydial challenge.
    Murthy AK; Li W; Guentzel MN; Zhong G; Arulanandam BP
    Vaccine; 2011 Mar; 29(14):2519-22. PubMed ID: 21300093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection.
    Lu H; Zhong G
    Infect Immun; 1999 Apr; 67(4):1763-9. PubMed ID: 10085016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
    Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
    Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.